 BASKING RIDGE, N.J., Dec. 09, 2020 GLOBE NEWSWIRE -- Caladrius Biosciences, Inc. Nasdaq: CLBS Caladrius or the Company, a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that David J. Mazzo, PhD, the Companys President and CEO, will be presenting at the 13th annual LD Micro Main Event investor conference on Monday, December 14, 2020 at 10:20 AM Eastern Time. 